Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
PEY.TO 0.26CP.TO -0.12BRK.B -0.78MSFT -6.85META 5.46BKNG 1.645HMP.TO -0.01SPGP 0.13
Valeant Pharmaceuticals (VRX.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Valeant Pharmaceuticals (VRX.TO)

0.00
-0.00 (0.00%)
39 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
HOLD

Valeant Pharmaceuticals(VRX.TO)

Apr 15, 2003
Has good legs under it. Prospects are good.
Photo of Michael SprungMichael SprungUnlock Rating
$62.00

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Apr 14, 2003
Getting a little high. If you own, take some profits.
Photo of Mark Jackson, CFAMark Jackson, CFAUnlock Rating
$60.50

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Apr 09, 2003
A good operation. Should go higher.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$59.40

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Apr 04, 2003
Concerned about their ability to raise cash.
Photo of Bill MacLachlanBill MacLachlanUnlock Rating
$61.87

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Mar 31, 2003
Great company. Nibble at it.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$58.71

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Mar 27, 2003
Thinks there will be more upside.
Photo of Robert FloydRobert FloydUnlock Rating
$59.25

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Mar 20, 2003
Good value and has good prospects.
Photo of Michael SprungMichael SprungUnlock Rating
$58.44

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Mar 20, 2003
Some risk. Volatile. Good company.
Photo of Ted MacklinTed MacklinUnlock Rating
$60.08

Stock price when the opinion was issued

Healthcare
WEAK BUY

Valeant Pharmaceuticals(VRX.TO)

Mar 18, 2003
Good growth rates. Be a little careful.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$58.50

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Mar 17, 2003
Well run. Good products. Good growth rate.
Photo of David BurrowsDavid BurrowsUnlock Rating
$58.78

Stock price when the opinion was issued

Healthcare
PAST TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Mar 03, 2003
(Was a top pick on Jan 10. Up 22%.) Still likes.
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBAUnlock Rating
$53.73

Stock price when the opinion was issued

Healthcare
WAIT

Valeant Pharmaceuticals(VRX.TO)

Feb 07, 2003
Just gave encouraging guidance. Have several products awaiting FDA approval. Wait for more news.
Photo of Robert FloydRobert FloydUnlock Rating
$47.48

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 31, 2003
Good long term. May drop a bit.
Photo of Andrew McCreathAndrew McCreathUnlock Rating
$43.60

Stock price when the opinion was issued

Healthcare
PAST TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Jan 27, 2003
(Was a top pick on Oct 16. Down 2.3%.) Sold out at a profit.Feels there are cheaper ways to play this sector.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$43.07

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Jan 21, 2003
Good growth.
Photo of John ZechnerJohn ZechnerUnlock Rating
$46.95

Stock price when the opinion was issued

Healthcare
Showing 556 to 570 of 714 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

CCO.TO 1.26$151.04
TOU.TO -0.47$60.79
BTE.TO -0.22$5.91
ADM -1.245$78.025
ATRL.TO 0.06$83.97

Today's Top Picks

PEY.TO 0.26$24.91
CP.TO -0.12$124.8
BRK.B -0.78$494.74
MSFT -6.85$392.91
META 5.46$598.94

Popular Articles

Latest Sell Signals

OTEX.TO 0.14$30.96
BSX 0.165$46.925
GIL.TO -16.24$70.39
SHOP.TO 1.22$158.49
WCN.TO 3.21$219.59

Most Recent Experts

Keith Richards

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

Gordon Reid

GoodReid Investment Counsel

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica